Therefore, the replenishment of adiponectin by transcriptional induction in adipocytes is believed to provide a new effective therapeutic approach to insulin resistance, type 2 diabetes, and related diseases. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.